Search research articles
Contact Us
Filters
Showing results (31-40 of 75) with videos related to
Page
of 8
Sort By:
JACC. Cardiooncology
|
February 19, 2025
Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline-Based Chemotherapy
Vencel Juhasz, Thiago Quinaglia, Zsofia D Drobni, et al.
Blood
|
November 8, 2019
Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, et al.
Blood Advances
|
September 18, 2024
Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis
Rathnam K Venkat, Robert A Redd, Amyah C Harris, et al.
International Journal of Cardiology
|
March 24, 2026
Atorvastatin and left ventricular strain during anthracycline-based chemotherapy
Vencel Juhasz, Thiago Quinaglia, Zsofia D Drobni, et al.
Blood
|
October 16, 2016
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma
Caron Jacobson, Nadja Kopp, Jacob V Layer, et al.
Blood Advances
|
November 15, 2024
A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma
Andrew Looka, David A Qualls, Daniel Matthews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2019
A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma
Irene M Ghobrial, Chia-Jen Liu, Robert A Redd, et al.
Frontiers in Cellular and Infection Microbiology
|
October 1, 2021
Type I Diabetes Mellitus Increases the Cardiovascular Complications of Influenza Virus Infection
Jane E Sinclair, Conor J Bloxham, Han Chiu, et al.
Cancer Immunology Research
|
October 15, 2016
Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status
Margaretha G M Roemer, Ranjana H Advani, Robert A Redd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2016
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Margaretha G M Roemer, Ranjana H Advani, Azra H Ligon, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 75) with videos related to
Sort By:
Page
of 8
JACC. Cardiooncology
|
February 19, 2025
Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline-Based Chemotherapy
Vencel Juhasz, Thiago Quinaglia, Zsofia D Drobni, et al.
Blood
|
November 8, 2019
Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, et al.
Blood Advances
|
September 18, 2024
Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis
Rathnam K Venkat, Robert A Redd, Amyah C Harris, et al.
International Journal of Cardiology
|
March 24, 2026
Atorvastatin and left ventricular strain during anthracycline-based chemotherapy
Vencel Juhasz, Thiago Quinaglia, Zsofia D Drobni, et al.
Blood
|
October 16, 2016
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma
Caron Jacobson, Nadja Kopp, Jacob V Layer, et al.
Blood Advances
|
November 15, 2024
A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma
Andrew Looka, David A Qualls, Daniel Matthews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2019
A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma
Irene M Ghobrial, Chia-Jen Liu, Robert A Redd, et al.
Frontiers in Cellular and Infection Microbiology
|
October 1, 2021
Type I Diabetes Mellitus Increases the Cardiovascular Complications of Influenza Virus Infection
Jane E Sinclair, Conor J Bloxham, Han Chiu, et al.
Cancer Immunology Research
|
October 15, 2016
Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status
Margaretha G M Roemer, Ranjana H Advani, Robert A Redd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2016
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Margaretha G M Roemer, Ranjana H Advani, Azra H Ligon, et al.
Page
of 8